Position in ESPR
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$0
+$0 QoQ
Shares Held
273,734
+57.5% QoQ
Ownership
0.106%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2022
8 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ESPR Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Mariner, LLC holds $80,358,857 across 29 Drug Manufacturers - Specialty & Generic names. ESPR ranks #29 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NBIX |
Neurocrine Biosciences Inc
|
155,039 | $26,130,272 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
23,965 | $12,984,955 | |
| 3 | HLN |
Haleon plc
|
771,516 | $7,198,243 | |
| 4 | ZTS |
Zoetis Inc.
|
96,951 | $6,966,897 | |
| 5 | AMRX |
Amneal Pharmaceuticals, Inc.
|
313,725 | $5,430,579 | |
| 6 | TAK |
Takeda Pharmaceutical Co Ltd
|
308,157 | $4,939,755 | |
| 7 | TEVA |
Teva Pharmaceutical Industries Ltd
|
125,843 | $4,263,560 | |
| 8 | LQDA |
Liquidia Corp
|
43,647 | $3,479,975 |
All Filings in ESPR
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | — | 273,734 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | — | 173,793 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | — | 278,661 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | — | 302,514 | Shares | Sole | 2025-11-14 | |
| 2023-09-30 | — | 26,130 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | — | 21,989 | Shares | Sole | 2023-08-11 | |
| 2022-12-31 | — | 17,786 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | — | 13,048 | Shares | Sole | 2022-11-10 | |
| No filing history on record for this holder in this stock. | ||||||